Investing in PrecisionPhage

At PrecisionPhage, we are pioneering a new era in medicine by harnessing the untapped potential of bacteriophages. Our cutting-edge research and development focus on leveraging these naturally occurring viruses to create highly targeted, effective, and safe therapies for bacterial infections, addressing the growing global threat of antibiotic resistance.

We are firmly settled on three major areas of bacteriophage research: bioinformatics, laboratory services and strain licensing.

PrecisionPhage Oy (Ltd.) is a private company registered in Finland.

The time of bacteriophages is now!

As antibiotic resistance continues to increase, bacteriophage-based therapies are poised to become a critical component of the fight against bacterial infections. By investing in PrecisionPhage, you join us in making an important contribution to global health.

A group of experts

We are a group of experienced researchers and entrepreneurs, ready to tackle one of the largest healthcare crises ever to face humanity.

Collection

Our phage collection currently spanning over 1,500 strains is a unique collection against the deadliest superbugs out there.

Bioinformatics

We leverage cutting-edge bioinformatics to unravel the secrets of the phage genome. Our deep understanding allows us to develop innovative applications harnessing the untapped potential of phages across diverse industries.

Laboratory

By hosting our state-of-the-art laboratory in central Finland, we are positioned to undertake any phage related tasks with expertise.

Our values

We combine academic rigour with innovativeness and a desire to advance healthcare with bacteriophage solutions.

Innovativeness

As a company we are committed to fostering a culture of exploration, eagerness and continuous learning.

Integrity

Coming from an academic background, we are driven by rigorous academic standards in everything that we do.

Collaboration

We recognise combating antimicrobial resistance as a global challenge. To overcome superbugs, we aspire to work together with other companies and academics.

Compassion

While we find phages fascinating as they are, what ultimately drives us is the benefit we can bring to patients' lives through phage therapy.

Let's get started!

To begin negotiations on investing in PrecisionPhage Oy, drop us a message!